ISRCTN10808433已完成未知
Randomized evaluation of All Babies Are Equal - a conditional cash transfer for routine childhood immunization in north-west Nigeria
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- GiveWell
- 入组人数
- 5,183
研究概览
简要总结
2020 Funder report results in https://www.idinsight.org/publication/impact-of-conditional-cash-transfers-on-routine-childhood-immunizations-evidence-from-north-west-nigeria/ (added 26/07/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Children aged 0 to 16 months can be enrolled in the program and incentives paid to their caregivers
- •2. Children aged 12 to 16 months will have their data measured at endline
- •3. All participants must reside in study clinic catchment areas.
- •4. Vaccination status will be measured by caregiver survey. Caregivers must consent to the survey
排除标准
- •1. Residence outside the study area (self-reported)
- •2. Outside the age range (self-reported)
研究者
相似试验
已完成
3 期
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX, in subjects >= 70 years of ageShingles10047438Herpes ZosterNL-OMON31421Sanofi Pasteur MSD S.N.C.150
进行中（未招募）
不适用
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 2-dose regimen of ProQuad® manufactured with rHA administered to healthy children from 9 months of ageMeasles, mumps, rubella and varicella vaccine administered to healthy children from 9 months of ageEUCTR2007-002468-88-FISanofi Pasteur MSD SNC1,620
进行中（未招募）
1 期
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX ®, in subjects = 70 years of ageEUCTR2007-000744-28-NLSanofi Pasteur MSD S.N.C.
进行中（未招募）
不适用
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 2-dose regimen of ProQuad® manufactured with rHA administered to healthy children from 9 months of ageMeasles, mumps, rubella and varicella vaccine administered to healthy children from 9 months of ageEUCTR2007-002468-88-DESanofi Pasteur MSD SNC1,620
进行中（未招募）
不适用
An open-label, randomised, comparative, multi-centre study of the immunogenicity and safety of a 1-dose regimen and different 2-dose regimens of a Zoster vaccine (Live), ZOSTAVAX , in subjects equal or over 70 years of age - NDEUCTR2007-000744-28-ITSanofi Pasteur MSD S.N.C.750